ArticleJournal of personalized medicine2022

Novel Thienyl-Based Tyrosine Kinase Inhibitors for the Treatment of Hepatocellular Carcinoma.

Andi Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.